Beilstein J. Nanotechnol.2026,17, 1142–1158, doi:10.3762/bjnano.17.78
; redox-responsive nanocarrier; viologencavitand; Introduction
Photodynamic therapy (PDT) is a minimally invasive, clinically approved approach widely utilized for cancer treatment, as well as various non-malignant conditions. It relies on three key components, namely, light, molecular oxygen, and a
THPP@p(MVCA-BAC) nanoplatform assembled via the copolymerization of a viologen-cavitand and a disulfide crosslinker. This system stabilizes hydrophobic THPP in its monomeric, non-aggregated state, maintains colloidal stability for at least three months, and enables GSH-triggered payload release. In
PDF
Figure 1:
Chemical structures of clinically approved porphyrin-based photosensitizers used in PDT.